Type to search

Huma Joins Forces With Independent Healthcare Provider to Launch Virtual Ward Service for the NHS | Pharmtech Focus
CHMP Recommends Approval of Lilly and Incyte's OLUMIANT® (baricitinib) as the First and Only Centrally-Authorized Treatment for Adults with Severe Alopecia Areata (AA) | Pharmtech Focus
Ginkgo Bioworks and First Serv Announce Plans to Develop and Implement Innovative Global Biosecurity Capabilities in Qatar | Pharmtech Focus